| 4N1Z: reference: A combination therapy for KRAS-driven lung adenocarcinomas using lipophilic bisphosphonates and rapamycin., Xia Y, Liu YL, Xie Y, Zhu W, Guerra F, Shen S, Yeddula N, Fischer W, Low W, Zhou X, Zhang Y, Oldfield E, Verma IM, Sci Transl Med. 2014 Nov 19;6(263):263ra161. doi: 10.1126/scitranslmed.3010382. PMID: 25411474 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).